BETHESDA, Md., Aug. 07, 2023 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc., (Nasdaq: GANX), a biotechnology company leading the discovery and...
Composite qEEG measure showed change from placebo after first dose of 5 mg Effect in the composite qEEG measured through...
– First patient dosed in phase 1/2 trial of TNG462, a next-generation PRMT5 inhibitor for the treatment of MTAP-deleted tumors...
Postpartum depression (PPD) approval based on results from two Phase 3 clinical trials; in the SKYLARK Study treatment with ZURZUVAE...
SOUTH SAN FRANCISCO and SAN DIEGO, Aug. 04, 2023 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology...
Completed single ascending dose (SAD) portion of Phase 1 trial evaluating OV329, a potential next-generation GABA-aminotransferase inhibitor Executed equity investment...
VoxNeuro’s technology addresses the increased demand for cognitive health assessments with a simplified and objective software solution Financing to support...
Live moderated webcast fireside chat on August 3rd at 11:35 AM ETHOUSTON, TX / ACCESSWIRE / August 3, 2023 /...
Company continued to see rapid progression and acceleration of enrollment with 180 patients enrolled to date across 46 clinical trial...
HOUSTON, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that...
Amplifire reveals outstanding electronic health records training outcomes at 2023 KLAS Arch Collaborative Learning Summit, spearheading healthcare education innovation. BOULDER,...
BOSTON, MA / ACCESSWIRE / August 2, 2023 / September 18th, 2023: The prestigious BWB Awards at Biotech Week Boston...
Approval opens up a new major market for CognICA, providing a solution to the urgent requirement for large-scale early detection...
VILNIUS, LITHUANIA / ACCESSWIRE / August 2, 2023 / As the second fastest-growing company in Europe, Kilo Health has a...
Data Presented at the Society of NeuroInterventional Surgery Annual Meeting Underscore the Utility of Company’s Zoom Access and Aspiration Portfolio...
MicroVention’s WEB System is the World Leader and Only PMA-Approved Intrasaccular Flow Disruptor; Advances Treatment of Wide-Neck Bifurcation Aneurysms with...
Grant Funds Will Support Proof-of-Concept Target Validation Studies for Preclinical Development of a Potential New Approach for the Prevention and...
Independent Data Monitoring Committee recommended REVEAL Phase 1/2 trial continuation and proceeding with dosing of second patient based on encouraging...
PALO ALTO, Calif., July 31, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180LS” or the “Company”), today...
Technology Enables Physicians to Remotely Make Pre-Diagnostic Assessment Regarding Whether an In-Person Diagnostic Examination of Ocular Anatomy is WarrantedPETALUMA, Calif.,...